It is expected to treat congenital or acquired, non-diffuse stenosis of left and right pulmonary artery or pulmonary artery branches
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are judged by the investigator to be suitable for implantation of pulmonary artery stents; 2. Patients (patients or immediate family members, guardians) agree to participate in this trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to cobalt alloys; 2. Pregnancy; 3. Those with contraindications to antiplatelet and anticoagulant therapy; 4. Severe calcified lesions of target blood vessels; 5. Those who are allergic to contrast media; 6. Cardiopulmonary function can not tolerate surgery; 7. Other lesions that are not conducive to stent delivery or balloon dilation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Restenosis rate of stent segment vessels; | — |
Secondary
| Measure | Time frame |
|---|---|
| Immediate postoperative success rate;Restenosis rate of stent segment vessels;Incidence of stent fracture;Incidence of stent re-expansion;Incidence of stent thrombosis; | — |
Countries
China
Contacts
Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine